BioAtla IncBCAB
Price$1.26

Financial Snapshot

Revenue, profitability, returns, debt, and capital allocation

Revenue $2MTTM through 31 Dec 2025
Net Income -$59.6MTTM through 31 Dec 2025
Free Cash Flow -$48.2MTTM through 31 Dec 2025

Margins

Current
Operating Margin-2,965.0%
Net Margin-2,980.0%

Returns

164.7%ROE

Balance Sheet Health

Debt / Equity0.00x
Current Ratio0.37x
Net Debt-$7.1Mnet cash position
Cash & Equivalents$7.1M

Quality Metrics

FCF Margin-2,410.0%
Earnings-Beat Rate75.0%

Dividend

No dividend

Segment Performance

No segment data available.

All values are periodic snapshots, not live quotes. Source dates are shown for reference.

Filing Detail Members

This section is available to registered members. Create a free account or sign in to unlock the full breakdown.

Sign in / Sign up
AI-assisted, source-linked narrative; figures from company filings (SEC EDGAR) and market data. Dates shown per section. Not investment advice. Terms of Use.